Skip to main content
. 2016 Nov 23;456:16–35. doi: 10.1016/j.mce.2016.11.018

Table 1.

Summary of preclinical investigations on miRNAs-mediated targeting therapeutics in bone-related disorders.

Disorders miRNA Delivery system Regulation Gene of interest In vitro/In vivo Outcome summary Reference
Osteoporosis (OP) mmu-miR-17/20a-5p Lipofectamine 2000 complexes RANKL MC3T3-E1, C57BL/6 mice 窗体顶端 (Shi et al., 2014)
Attenuated Dexamethasone- induced osteoclast differentiation and function
mmu-miR-29a-3p Lentivirus Dkk-1 SD rat Protects against GC-induced bone loss and fragility (Wang et al., 2013b)
mmu-miR-34a-5p X-tremeGENE Transfection Reagent CDK4, CDK6, C57BL/6 mice 窗体顶端 (Kang et al., 2016a)
Cyclin D1 Impaired BMSC osteogenic differentiation and aggravated osteoporsis
mmu-miR-140/214-3p Baculovirus vectors JAG1, Tmem119, ATF-4, Osterix SD rat Promoted bone formation and mitigated excessive bone resorption (Li et al., 2016c)
mmu-miR-34a-5p Lipofectamine
RNAi MAX
Tgif2 C57BL/6J mice Elevated bone resorption and reduced bone mass (Krzeszinski et al., 2014)
Bone defect hsa-miR-21-5p Chitosan/hyaluronic acid nanoparticles Runx2 hBMSC Significantly improved osteogenesis (Schoolmeesters et al., 2009, Wang et al., 2015b)
mmu-miR-26a-5p Lipofectamine 2000 complexes OCN, COL1 窗体顶端 Satisfactory bone repair in tibial defect (Wang et al., 2015a)
Rabbit ASC
mmu-miR-29a-3p Gelatin solutions IGF1, tfgb1 MC3T3-E1 Significantly enhanced ECM deposition (James et al., 2014)
mmu-miR-31-5p Lipofectamine 2000 complexes Runx2, Satb2 SD rat Good biocompatibility and bone regeneration (Deng et al., 2014, Deng et al., 2013)
mmu-miR-138-5p Lipofectamine 2000 complexes Runx2 C57BL/6 mice, 窗体顶端 (Yan et al., 2014)
rat BMSC Massive bone with good vascularization
hsa-miR-148b-3p Silver nanoparticle complexes Runx2, OCN hASC Promoted osteogenic differentiation (Qureshi et al., 2013)
Primary bone tumor hsa-miR-20a-5p Lipofectamine 2000 complexes EGR MG63, SaSO2, SW1353 Inhibited cell proliferation and cycle (Zhou et al., 2015)
hsa-miR-22-3p Lipofectamine 2000 complexes ACLY SaSO2, PC3, Hela, A549 Inhibited growth and metastasis of various tumors (Xin et al., 2016)
hsa-miR-26a-5p Lentivirus vector Jagged1 MG63, SaSO2, 143B, U2OS, BALA/c nude mice Suppressed CSCs phenotype and tumor growth (Lu et al., 2016)
hsa-miR-106a-5p Lipofectamine 2000 complexes HMGA2 MG63, SaSO2, HOS, U2OS Inhibited proliferation, migration and invasion (He et al., 2016)
hsa-miR-106b-5p FuGENE HD transfection agent RANKL, IL-8, MMP2, TWIST mice BMM, GCTSC, OVX mouse Inhibited bone resorption and osteolysis (Wang et al., 2015c)
hsa-miR-126-5p FuGENE HD transfection agent MMP-13, PTHrP mice BMM, GCTSC Suppression of osteoclast differentiation and bone resorption (Wu et al., 2014a, Zhou et al., 2014)
hsa-miR-126-5p Lipofectamine 2000 complexes Sirt 1 SaSO2 窗体顶端 (Shi et al., 2015, Xu et al., 2013)
inhibited proliferation, migration, invasion and epithelial-mesenchymal transition
hsa-miR-204-5p
hsa-miR-145-5p Lipofectamine 3000 complexes FLI-1 MG63, SaSO2 Inhibited tumor progression (Wu et al., 2016b)
hsa-miR-409-3p Lipofectamine 2000 complexes Catenin-δ1 U2OS Inhibited migration and invasion (Wu et al., 2016a)
hsa-miR-646 Lipofectamine 2000 complexes FGF-2 MG63, SaSO2, HOS, U2OS Suppression of metastasis (Sun et al., 2015)
Secondary metastasis hsa-miR-34a-5p Lentivirus vector TCF-7 PC3, RasB1 Inhibited bone metastasis of Ras-activated PC (Chen et al., 2015)
hsa-miR-335-5p, Lentivirus vector eNOS PC3 Inhibited bone metastasis of PC (Fu et al., 2015)
hsa-miR-543
Osteoarthritis (OA) hsa-miR-23a-3p, Lipofectamine 2000 complexes Samd3 SW1353 Promoted type II collagen and aggrecan expression (Kang et al., 2016b, Li et al., 2015)
hsa-miR-16-5p
hsa-miR-139-5p Lipofectamine
RNAi MAX
EIF4G2, IGF1R CHON-001 Protective effects on chondrocyte proliferation and migration (Hu et al., 2016)
hsa-miR-142-3p Lipofectamine 2000 complexes HMGB-1 C57BL/6 mice Suppressed inflammation and chondrocyte apoptosis (Wang et al., 2016b)
mmu-miR-210-5p Geneporter 2
Transfection Reagent
DR6 SD rat Suppressed inflammation and chondrocyte apoptosis (Zhang et al., 2015a)
hsa-miR-365a-3p Lipofectamine 2000 complexes HDAC4 Primary chondrocyte from OA patient Inhibited expression of MMP13 and Col X (Yang et al., 2016)